Earnings · China A-shares
Jiangxi Fushine Pharmaceutical Co., Ltd. Class A (300497) earnings
Jiangxi Fushine Pharmaceutical Co., Ltd. Class A published its Q3 report on 2026-10-23: net profit +742.04% year on year, +519.43% excluding one-off items. Wave Radar's earnings-quality score is 82 of 100 (Sound). The stock moved -7.11% in the 3 trading days after the report.
- Report
- Q3 report
- Published
- 2026-10-23
- Period end
- 2026-09-30
- Net profit YoY
- +742.04%
- Excl. one-offs YoY
- +519.43%
- Net profit QoQ
- +95.21%
- Result
- Great
- Quality score
- 82
- Quality
- Sound
Stock move after the report
Trading days from the first tradeable session; dividend-adjusted. "vs index" is the excess return over CSI 300 for A-shares.
| After | Return | vs index |
|---|---|---|
| 1 day | -3.59% | — |
| 3 days | -7.11% | — |
| 7 days | -9.39% | — |
| 14 days | -3.73% | — |
Report history
Over the last 8 reports, net profit grew year on year in 6 of them. The stock rose in the 3 trading days after 2 of 6 reports (average -2.61%).
| Report | Published | Net profit | Profit YoY | Excl. one-offs YoY | Revenue YoY | EPS | ROE | 3 days after | 30 days after | 30d vs index |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026 Q3 report | 2026-10-24 | ¥402.89M | +742.04% | +519.43% | +101.49% | 0.75 | 16.90% | -7.11% | — | — |
| 2026 interim report | 2026-08-12 | ¥176.94M | +2660.26% | +644.83% | +72.59% | 0.33 | 7.78% | -1.34% | +10.35% | +12.66% |
| 2026 Q1 report | 2026-04-28 | ¥61.20M | +2633.39% | +366.63% | +53.09% | 0.11 | 2.76% | -2.13% | -22.75% | -22.12% |
| 2025 annual report | 2026-04-28 | -¥55.03M | +79.78% | +72.74% | +0.61% | -0.10 | -2.52% | -2.13% | -22.75% | -22.12% |
| 2025 Q3 report | 2025-10-28 | -¥62.75M | -1.09% | +5.52% | -21.24% | -0.12 | -2.92% | +0.79% | +46.83% | +50.21% |
| 2025 interim report | 2025-08-27 | -¥6.91M | +69.23% | +34.91% | -24.58% | -0.01 | -0.32% | -6.58% | -4.04% | -7.82% |
| 2025 Q1 report | 2025-04-26 | ¥2.24M | +52.46% | — | -31.35% | 0.00 | 0.10% | +0.72% | +12.89% | +9.64% |
| 2024 annual report | 2025-04-26 | -¥272.10M | -35.51% | -54.12% | -26.83% | -0.51 | -11.62% | +0.72% | +12.89% | +9.64% |
The last 8 reports. Net profit is attributable to shareholders and year-to-date (a Q3 report covers the first nine months). Moves count trading days from the first tradeable session after publication; "30d vs index" is the excess return over CSI 300.
How to read this
Results are grouped by reported profit growth (great, good, neutral, bad or a loss). For China A-shares the quality score starts at 100 and loses points for gaps a reader can check: operating cash falling short of profit, receivables or inventory outrunning revenue, profit that rests on one-off items or subsidies, heavy goodwill and a qualified audit opinion.
Figures are generated automatically from Wave Radar's published market data and refresh after each market close.